Physician profile
John S Steinberg
NPI 1265432009
$166,356.54
in general payments reported to CMS, 2019-2025
34 companies · $95K in 2025
The $95K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,454 · 2020: $15K · 2021: $16K · 2022: $3,332 · 2023: $2,342 · 2024: $33K · 2025: $95K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $87K · Travel and Lodging: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $4,056 · Long Term Medical Supply Or Device Loan: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $87,005.00 |
| Travel and Lodging | $24,276.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,781.25 |
| Food and Beverage | $4,055.96 |
| Long Term Medical Supply Or Device Loan | $944.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $92,333.64 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $26,682.13 | 2024-2025 | V.A.C. Veraflo, V.A.C. Dermatac, Prevena |
| Medline Industries Lp | $23,578.41 | 2019-2023 | |
| Medshape, INC. | $8,042.71 | 2021 | |
| Polynovo North America LLC | $3,667.85 | 2023-2025 | Novosorb Btm |
| Averitas Pharma INC. | $3,369.16 | 2023-2025 | Qutenza |
| Ets Wound Care LLC | $3,033.80 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Paratek Pharmaceuticals, INC. | $1,702.00 | 2021 | |
| Stryker Corporation | $1,131.02 | 2019-2025 | Hoffmann, Augment Injectable, Fuseforce |
| Smith+Nephew, INC. | $597.86 | 2019-2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Kci USA, INC. | $450.00 | 2020-2021 | |
| Organogenesis INC. | $387.74 | 2019-2025 | Puraply Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $175.28 | 2022-2023 | |
| Osteomed LLC | $173.34 | 2019 | |
| Mimedx Group, INC. | $141.46 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $121.24 | 2022-2024 | Hydrofera Blue |
| Tactile Systems Technology INC | $105.93 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Fusion Orthopedics USA, LLC | $87.27 | 2025 | |
| Embody, INC. | $87.15 | 2022 | |
| Reapplix INC. | $80.61 | 2023 | 3c Patch Kit - Box |
| Grt US Holding, INC. | $54.98 | 2021-2022 | |
| Ossio INC | $54.96 | 2021 | |
| Bone Support INC. | $43.91 | 2024 | Ceramentbone Void Filler, Cerament G |
| Polarityte, INC. | $42.77 | 2019 | |
| Davol INC. | $35.97 | 2023 | |
| Depuy Synthes Sales INC. | $27.94 | 2025 | Motoband, Minibunion, Na |
| Next Science LLC | $26.86 | 2023 | Blastx, Xperience, Surgx |
| Acera Surgical, INC. | $26.43 | 2021 | |
| Urgo Medical North America, LLC | $20.32 | 2025 | Urgok2 |
| Acumed LLC | $17.68 | 2022 | |
| Cashflow Solutions, LLC | $15.87 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Ovik Health, LLC | $15.51 | 2024 | Agile |
| Trimed, INC. | $13.33 | 2024 | |
| Terumo Medical Corporation | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$10,612.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.